Takayuki Kinoshita

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Novel combination of serum microRNA for detecting breast cancer in the early stage

Akihiko Shimomura, Sho Shiino, Junpei Kawauchi et al. · Cancer Science · 2016 · 363 citations · Full text

Medicine, Cancer Biology, Oncology +15

Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer

Makiko Ono, Hitoshi Tsuda, Chikako Shimizu et al. · Breast Cancer Research and Treatment · 2011 · 306 citations

Medicine, Immunology, Oncology +15

⁶⁴Cu-DOTA-Trastuzumab PET Imaging in Patients with HER2-Positive Breast Cancer

Kenji Tamura, Hiroaki Kurihara, Kan Yonemori et al. · Journal of Nuclear Medicine · 2013 · 295 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Changes in tumor expression of HER2 and hormone receptors status after neoadjuvant chemotherapy in 21 755 patients from the Japanese breast cancer registry

Naoki Niikura, Ai Tomotaki, Hiroaki Miyata et al. · Annals of Oncology · 2015 · 182 citations

Medicine, Oncology, Breast Oncology +14